SELLAS Life Sciences Group, Inc. (SLS)
Data as of , from SEC Form 4 filings.
See up to 3 months of SLS. The 7-day demo opens the 1M and 3M ranges and puts SLS on your watchlist.
Start 7-day demoLatest SLS insider trades
About SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. is an SEC registrant, filing under CIK 0001390478, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
SLS Form 4 activity by transaction type, last 90 days
No Form 4 activity for SLS in the last 90 days.
SLS insider transactions (Form 4)
99 Form 4 filings on record, the earliest from Dec 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Angelos M. Stergiou - Officer | Grant or award | Common Stock | 1,065,000 footnote F1 | $0.00 | - | |
| ||||||
| Dragan Cicic - Officer | Other | Common Stock | 63,800 footnote F2 | $1.50 | $96K | |
| ||||||
| John Thomas Burns - Officer | Other | Common Stock | 58,592 footnote F2 | $1.50 | $88K | |
| ||||||
| Angelos M. Stergiou - Officer | Other | Common Stock | 187,066 footnote F2 | $1.50 | $281K | |
| ||||||
| Katherine Bach Kalin - Director | Open-market purchase | Common Stock | 63,400 | $1.59 footnote F1 | $101K | |
| ||||||
| Nostrand Robert L. van - Director | Open-market purchase | Common Stock | 10,000 | $1.48 | $15K | |
| Dragan Cicic - Officer | Other | Common Stock | 8,256 | $1.13 | $9K | |
| Angelos M. Stergiou - Officer | Other | Common Stock | 28,289 | $1.13 | $32K | |
| John Thomas Burns - Officer | Other | Common Stock | 7,165 | $1.13 | $8K | |
SLS insider trading FAQ
What is the latest insider trade for SLS?
SELLAS Life Sciences Group, Inc. (SLS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-18. The full record for SLS runs to 9 Form 4 filings, the earliest from 2024-12-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SLS stock?
No insider purchases of SLS were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling SLS stock?
No insider sales of SLS were filed in the last 90 days.
Where can I see SLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SLS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Angelos M. Stergiou view on EDGAR
- - Dragan Cicic view on EDGAR
- - John Thomas Burns view on EDGAR
- - Angelos M. Stergiou view on EDGAR
- - Katherine Bach Kalin view on EDGAR
- - Nostrand Robert L. van view on EDGAR
- - Dragan Cicic view on EDGAR
- - Angelos M. Stergiou view on EDGAR
- - John Thomas Burns view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SLS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SLS with a 7-day demo
- SLS on your watchlist
- Every SLS Form 4 filing on record
- Up to 3 months of SLS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
